Filter posts

Expanding the Role of Patients in Drug Development

Working alongside scientists, universities, and biotech companies, patients and patient organizations have the ability to …

BIO 2015 Kicks Off: Patient-Focused Drug Development Key Theme of Day One

The BIO International Convention kicked off in Philadelphia today with a strong¬†emphasis on patient-focused drug …

Prepare and Protect from Biological Threats

Yesterday the Alliance for Biosecurity hosted a panel that outlined the important role played by …

MIT Hacking Medicine Presents Idea Design Studio at #BIO2015

Have you ever wanted to improve your healthcare experience? Have you ever felt like you …

The Convergence of BioPharma and Digital Medicine

Our newfound capability of digitizing the medical essence of human beings with biosensors, imaging, sequencing …

Out of Africa: Biomedical Innovation and Expertise

Scientific research holds the key to unlocking creative and effective solutions for alleviating the burden …

John Lechleiter Forbes Op-Ed: Debunking the Five Big Myths About 'Big Pharma'

This week, Eli Lilly and Company President, Chairman and CEO John Lechleiter refutes five big …

Leading MIT Scientist, Professor and Entrepreneur, Robert Langer, to Speak at BIO 2015

In a recent Boston Globe article, MIT standout and Queen Elizabeth Prize for Engineering recipient, …

United Health To Congress: Let Cancer Patients Eat Gauze (Op-Ed in The Hill)

Jonathan Wilcox’s op-ed in The Hill today highlights the growing challenge of insurance company¬†tactics that …

Dr. Eric Topol to Keynote Wednesday Luncheon at #BIO2015

This week, we are very excited to announce that Dr. Eric J. Topol, director of …